GL1X · GenesisL1 explorer

MolNFT v1 · #114758 · protein

Crystal structure of pcdn-27A, an antibody from the pcdn family of HIV-1 antibodies

5BZD · 5G8 HIV antibody light chain: “Crystal structure of pcdn-27A, an antibody from the pcdn family of HIV-1 antibodies”. X-ray diffraction, 11 pockets (best druggability 0.67). MolNFT v1 #114758 on GenesisL1: 3D structure, binding sites…

PDB
5BZD
Type
protein
Length
882 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
5G8 HIV antibody light chain; 5G8 HIV antibody heavy chain
Pockets
11 · best druggability 0.67

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A5G8 HIV antibody light chainprotein2136% helix, 56% strand—
B5G8 HIV antibody heavy chainprotein2296% helix, 49% strand—
C5G8 HIV antibody light chainprotein2148% helix, 52% strand—
D5G8 HIV antibody heavy chainprotein2267% helix, 51% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18150.670.7464empty
26930.660.7557empty
33940.600.7648empty
42580.540.7634empty
5540.450.8521GOL

Interfaces

3 interfaces between chains.

  • C–D · 1765 Ų buried · 16 hydrogen bonds · protein-protein
  • A–B · 1646 Ų buried · 14 hydrogen bonds · protein-protein
  • B–D · 248 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 5BZD · Crystal Structure of PCDN-27A, an antibody from the PCDN family of HIV-1 antibodies · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.